本页面由Tiger Trade Technology Pte. Ltd.提供服务

Sonnet BioTherapeutics Holdings, Inc.

1.26
0.0000
成交量:- -
成交额:- -
市值:891.81万
市盈率:-0.25
高:1.26
开:1.26
低:1.26
收:1.26
52周最高:5.95
52周最低:1.26
股本:707.79万
流通股本:680.21万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-5.0074
每股收益(LYR):-11.3504
净资产收益率:-310.85%
总资产收益率:-112.17%
市净率:0.83
市盈率(LYR):-0.11

数据加载中...

2023/10/24

SEC问询函

Form CORRESP - Correspondence
2023/10/20

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/10/05

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/09/29

SEC问询函

Form CORRESP - Correspondence
2023/09/29

SEC问询函

Form CORRESP - Correspondence
2023/09/28

SEC问询函

Form CORRESP - Correspondence
2023/09/28

SEC问询函

Form CORRESP - Correspondence
2023/09/28

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/09/20

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2023/09/19

重要事件披露

Form 8-K - Current report
2023/09/01

重要事件披露

Form 8-K - Current report
2023/09/01

重要事件披露

Form 8-K - Current report
2023/08/22

重要事件披露

Form 8-K - Current report
2023/08/21

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/08/14

重要事件披露

Form 8-K - Current report
2023/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/07

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/08/07

SEC问询函

Form CORRESP - Correspondence
2023/07/28

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2023/07/21

重要事件披露

Form 8-K - Current report